☰

cached image

Lon S. Schneider, MD, MS

Affiliations: 
Psychiatry and the Behavioral Sciences and Neurology University of Southern California, Los Angeles, CA, United States 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=125
Website:
http://www.usc.edu/uscnews/experts/945.html
Google:
"Lon Schneider"
Bio:

http://www.insidermedicine.com/archives/In_the_Spotlight_-_Dr_Lon_Schneider_MD_2687.aspx

http://www.alzforum.org/com/res/detail.asp?id={E6787F54-6A48-4124-8151-93EE69EF470F}

http://cadc.ucsf.edu/cadc/centers/leadership/lschneider

Mean distance: 21.34
 
Cross-listing: Alzheimer's Tree

Tree Publications Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Jason T. Olin post-doc USC

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lee J, Howard RS, Schneider LS. (2024) The Current Landscape of Prevention Trials in Dementia. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 19: 228-247
Lee J, Howard RS, Schneider LS. (2024) The Current Landscape of Prevention Trials in Dementia. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 19: 228-247
Goldberg TE, Lee S, Devanand DP, et al. (2023) Comparison of relative change with effect size metrics in Alzheimer's disease clinical trials. Journal of Neurology, Neurosurgery, and Psychiatry
Schneider LS. (2023) What the Gantenerumab Trials Teach Us about Alzheimer's Treatment. The New England Journal of Medicine. 389: 1918-1920
Schneider LS. (2023) Alzheimer's and Dementia Guidelines and Tables. Psychopharmacology Bulletin. 53: 8-65
LaBarbera KM, Sheline YI, Izzo NJ, et al. (2023) A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter. Translational Neurodegeneration. 12: 24
Lee J, Howard RS, Schneider LS. (2022) The Current Landscape of Prevention Trials in Dementia. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 19: 228-247
Wang G, Liu L, Li Y, et al. (2022) Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 8: e12286
Raikes AC, Hernandez GD, Matthews DC, et al. (2022) Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes. Alzheimer's & Dementia (New York, N. Y.). 8: e12258
Schneider LS, Qiu Y, Thomas RG, et al. (2021) Impact of potential modifications to Alzheimer's disease clinical trials in response to disruption by COVID-19: a simulation study. Alzheimer's Research & Therapy. 13: 201
See more...